Query
Find articles
Pick a keyword, optionally a second one to combine it with (and, or, either but not both, or but not), then narrow the articles down by text, source and time range. Keywords update the results right away; filters apply with their button.
Query
How they overlap
Of the articles on each keyword in the last 7 days, with the same text and sources, how many also mention the other. Per lean: the share of its outlets' articles on drug approval that mention Robert F. Kennedy Jr..
100.0% of the 2 articles on drug approval also mention Robert F. Kennedy Jr., as do 5.4% of the 37 articles on Robert F. Kennedy Jr..
- Left-leaning1 of 1 article
- 100.0%
- Least biased1 of 1 article
- 100.0%
- Right-leaningno article on drug approval
- –
Who picked it up when
The Hill mentioned it first (Oct 28, 2026, 2:18 PM EDT). Left-leaning outlets followed within the hour. No right-leaning outlet mentioned it.
One row per source with a matching article, from the most left-leaning on top: a dot for each article, on a bar for each stretch of its coverage (a pause of more than 24 hours starts a new one). Hover or tap a dot for the headline, click it to read the article.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
Results
2 articles mention drug approval and Robert F. Kennedy Jr. in the last 7 days (Oct 22 to Oct 28).
| Article | |||
|---|---|---|---|
| The Guardian | FDA scientists opposed Trump administration’s move to ease peptide accessThe Guardian Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr , was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development. The document posted online on Wednesday by Kennedy’s Department of Health and Human Services (HHS) covers a handful of injectable peptides promoted within the wellness industry for building muscle, healing injuries and boosting energy. Continue reading... | 0.65 | |
| The Hill | HHS to allow sale of unapproved peptides under reviewThe Hill The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the "Make America Healthy Again" (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion... | 0.50 |
Source leans by Media Bias/Fact Check.
Narrow further
Other keywords in the matching articles: the share of them that mention each, with the number of articles. The search icon searches for drug approval and that keyword instead of Robert F. Kennedy Jr., keeping the text, sources, source type and time range.
Coverage by source
The share of each source's stories in the last 7 days that match the query, from left to right. Sort the table to reorder the bars.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
| The Guardian | 0.1% | 1 | 695 |
| The Hill | 0.2% | 1 | 434 |
Coverage by lean
The share of stories that match the query, in the last 7 days, averaged over the outlets of each political lean with at least 3 stories. The groups differ in size, so a single outlet weighs more in the smaller ones.
- Left-leaning1 of 15 sources
- <0.1%
- Least biased1 of 8 sources
- <0.1%
- Right-leaning0 of 15 sources
- 0.0%
Lean index −1.1: covered more by left-leaning outlets
Each outlet at its MBFC bias score, from −10 (far left) to +10 (far right), as high as the share of its stories that match the query. The lean index is the average score of the outlets covering it, weighted by that share.
lean indexour sources' average (+0.4)leftcenterright
Bias scores by Media Bias/Fact Check.
Source leans based on ratings by Media Bias/Fact Check.